Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

lab specimen

ARUP & Mayo Respond To New Market Cycle

CEO SUMMARY: Since the beginning of 2002, several important events changed the competitive status quo among the nation’s leading providers of hospital send-out testing. As part of its ongoing assessment of this market segment, THE DARK REPORT provides strategic management insights from …

Read More



Will “Free Testing” Ploy Financially Affect Labs?

CEO SUMMARY: It’s a marketing scheme which public lab companies have quietly used for years. Now there is evidence that the use of “Waiver of Charges to Managed Care Patients” (free testing) seems to be on the increase, raising new questions about how and why competitive practices a…

Read More



More Lab Consolidation: LabCorp Buys Dynacare

CEO SUMMARY: Recent weeks brought many rumors about an impending deal between Laboratory Corporation of America and Dynacare. That speculation was ended last week when it was disclosed that LabCorp would pay about $685 million in cash, stock and assumed debt to acquire Dynacare. The acqui…

Read More



FNA Clinic Business Becomes Part of Unilab

CEO SUMMARY: Pathology has a new business model entering the marketplace. The goal of FNA Clinics of America, Inc. is to offer patients speedy access to the FNA procedure and provide referring physicians with a final diagnosis within hours of the FNA procedure. Unilab Corporation recogniz…

Read More



2001’s Ten Big Stories Presage Future Direction

CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…

Read More



Terrorist Attacks Affect Many of Nation’s Labs

CEO SUMMARY: Following terrorist attacks in New York City and Washington, DC, the total shutdown of commercial air traffic in the United States for 48 hours disrupted the regular shipment of reference and esoteric lab specimens to national laboratories. Swiftly-implemented contingency eff…

Read More



In the Aftermath of Terror: Labs Deal With New Issues

SELDOM DO I WRITE IN FIRST PERSON to our clients and regular readers. Yet the events of the past few weeks—and the uncertain path our nation is about to take into the future—impel me to share some insights and thoughts. Like most of you, I watched the television coverage of these tragic events a…

Read More



Medical Errors Reporting Will Impact Labs

CERTAINLY HIPAA SEEMS TO BE GETTING LOTS OF ATTENTION by all categories of healthcare providers, including laboratories. But I think the movement to disclose medical errors may eventually prove to be the more serious issue for clinical laboratories and anatomic pathology groups. Our members and clie…

Read More



Analysis of Lab Testing Market Reveals Competitive Shifts

CEO SUMMARY: Even as public lab and anatomic pathology companies enjoy sustained growth in specimen volumes and revenues, fundamental shifts in the basic marketplace have changed the competitive environment. Surprisingly, the most open market segment is anatomic pathology specimens referr…

Read More



“June 11, 2001 Intelligence: Late Breaking Lab News”

Here’s a late-breaking story: Tropical Storm Allison hammered Houston and East Texas over the weekend. More than 30 inches of rain caused wide-spread flooding in the Houston Metropolitan Area. Hospitals in the Medical Center were hard hit. Memorial Hermann Hospital closed on Saturd…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;